
KRSNAA DIAGNOSTICS Latest Share Price (KRSNAA)
TODAY IN ONE LINE
KRSNAA rose 2.1% on above-average volume (3.1x avg), outperforming Nifty's -0.6% move, supported by recent strong earnings.
With a market cap of ₹1,720.22 Cr., it trades at a P/E of 17.54. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
KRSNAA DIAGNOSTICS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 102.1% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 15.1% and Profit up 48.5%
- ●Healthy Operating MarginsOPM is structurally strong at 21.3%
- ●Reasonable ValuationTrading at a moderate P/E of 17.7x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Rising Receivables vs SalesReceivables grew 54.3% outpacing sales growth of 15.7%
Latest KRSNAA DIAGNOSTICS News
What changed recently?
Recent events, corporate actions, and announcements.
KRSNAA DIAGNOSTICS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for KRSNAA DIAGNOSTICS, framed against the sector median so the premium or discount is obvious at a glance.
KRSNAA DIAGNOSTICS trades at a P/E of 17.54× and P/B of 1.66×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
KRSNAA DIAGNOSTICS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for KRSNAA DIAGNOSTICS — derived from the latest tape, not yesterday's close.
KRSNAA DIAGNOSTICS last traded at ₹528.75 with an intraday range of ₹509.55–₹540.5 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹528.75| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 604.88 | +76.13 | +14.40% |
| R3 | 573.93 | +45.18 | +8.55% |
| R2 | 557.22 | +28.47 | +5.38% |
| R1 | 542.98 | +14.23 | +2.69% |
| PIVOT | 526.27 | -2.48 | -0.47% |
| CURRENT | 528.75 | — | — |
| S1 | 512.03 | -16.72 | -3.16% |
| S2 | 495.32 | -33.43 | -6.32% |
| S3 | 481.08 | -47.67 | -9.01% |
| S4 | 450.13 | -78.62 | -14.87% |
KRSNAA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹511.2–₹515.85
Trading Above opening range, showing Bullishness
KRSNAA DIAGNOSTICS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for KRSNAA DIAGNOSTICS — consolidated or standalone — with margins, YoY growth and key ratios inline.
KRSNAA DIAGNOSTICS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,720.22 Cr. and reported EPS of ₹7.58.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 773 | 773 ▲ 0.0% |
| Sales Growth YoY %Derived | 7.75% | 7.75% |
| Other Income | 43 | 43 ▲ 0.0% |
| Total Income | 816 | 816 ▲ 0.0% |
| 179 | 179 ▲ 0.0% | |
| Gross ProfitDerived | 594 | 594 ▲ 0.0% |
| Gross Margin %Derived | 76.83% | 76.83% |
| 382 | 382 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 212 | 212 ▲ 0.0% |
| OPM %Derived | 27.42% | 27.42% |
| 125 | 125 ▲ 0.0% | |
| Profit Before Tax (PBT) | 130 | 130 ▲ 0.0% |
| 29 | 29 ▲ 0.0% | |
| Effective Tax %Derived | 22.18% | 22.18% |
| Total Profit for Period | 101 | 101 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 101 | 101 ▲ 0.0% |
| Net Profit Margin %Derived | 13.13% | 13.13% |
| PAT Growth YoY %Derived | 30.70% | 30.70% |
| Earnings Per Share (EPS ₹) | 31.27 | 31.27 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% |
| Share of Profit from Associates/JVs | -0 | -0 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 686 | 686 ▲ 0.0% |
| Material Cost % of RevenueDerived | 23.17% | 23.17% |
| Employee Cost % of RevenueDerived | 18.18% | 18.18% |
| Other Cost % of RevenueDerived | 31.23% | 31.23% |
| Interest Coverage (x)Derived | 3.53x | 3.53x |
| Period | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 455 | 455 ▲ 0.0% | 487 ▲ 7.0% | 487 ▲ 0.0% | 620 ▲ 27.2% | 620 ▲ 0.0% | 717 ▲ 15.7% | 717 ▲ 0.0% | 773 ▲ 7.8% | 773 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 6.95% | 6.95% | 27.20% | 27.20% | 15.74% | 15.74% | 7.75% | 7.75% | |
| Other Income | 15 | 15 ▲ 0.0% | 19 ▲ 30.0% | 19 ▲ 0.0% | 17 ▼ 13.3% | 17 ▲ 0.0% | 26 ▲ 52.0% | 26 ▲ 0.0% | 43 ▲ 69.9% | 43 ▲ 0.0% | |
| Total Income | 470 | 470 ▲ 0.0% | 507 ▲ 7.7% | 507 ▲ 0.0% | 636 ▲ 25.7% | 636 ▲ 0.0% | 743 ▲ 16.7% | 743 ▲ 0.0% | 816 ▲ 9.9% | 816 ▲ 0.0% | |
60 | 60 ▲ 0.0% | 74 ▲ 23.0% | 74 ▲ 0.0% | 141 ▲ 90.1% | 141 ▲ 0.0% | 169 ▲ 20.0% | 169 ▲ 0.0% | 179 ▲ 5.8% | 179 ▲ 0.0% | ||
| Gross ProfitDerived | 395 | 395 ▲ 0.0% | 413 ▲ 4.5% | 413 ▲ 0.0% | 479 ▲ 15.9% | 479 ▲ 0.0% | 548 ▲ 14.5% | 548 ▲ 0.0% | 594 ▲ 8.4% | 594 ▲ 0.0% | |
| Gross Margin %Derived | 86.76% | 86.76% | 84.77% | 84.77% | 77.24% | 77.24% | 76.40% | 76.40% | 76.83% | 76.83% | |
264 | 264 ▲ 0.0% | 291 ▲ 10.2% | 291 ▲ 0.0% | 334 ▲ 15.0% | 334 ▲ 0.0% | 358 ▲ 7.0% | 358 ▲ 0.0% | 382 ▲ 6.7% | 382 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 131 | 131 ▲ 0.0% | 122 ▼ 7.0% | 122 ▲ 0.0% | 144 ▲ 17.9% | 144 ▲ 0.0% | 190 ▲ 31.8% | 190 ▲ 0.0% | 212 ▲ 11.4% | 212 ▲ 0.0% | |
| OPM %Derived | 28.87% | 28.87% | 25.11% | 25.11% | 23.28% | 23.28% | 26.51% | 26.51% | 27.42% | 27.42% | |
60 | 60 ▲ 0.0% | 61 ▲ 2.7% | 61 ▲ 0.0% | 91 ▲ 48.1% | 91 ▲ 0.0% | 113 ▲ 24.1% | 113 ▲ 0.0% | 125 ▲ 10.5% | 125 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 87 | 87 ▲ 0.0% | 80 ▼ 7.3% | 80 ▲ 0.0% | 70 ▼ 12.7% | 70 ▲ 0.0% | 103 ▲ 46.7% | 103 ▲ 0.0% | 130 ▲ 27.0% | 130 ▲ 0.0% | |
18 | 18 ▲ 0.0% | 18 ▼ 0.2% | 18 ▲ 0.0% | 13 ▼ 27.2% | 13 ▲ 0.0% | 25 ▲ 90.4% | 25 ▲ 0.0% | 29 ▲ 15.4% | 29 ▲ 0.0% | ||
| Effective Tax %Derived | 20.95% | 20.95% | 22.56% | 22.56% | 18.81% | 18.81% | 24.42% | 24.42% | 22.18% | 22.18% | |
| Total Profit for Period | 68 | 68 ▲ 0.0% | 62 ▼ 9.2% | 62 ▲ 0.0% | 57 ▼ 8.5% | 57 ▲ 0.0% | 78 ▲ 36.5% | 78 ▲ 0.0% | 101 ▲ 30.7% | 101 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 68 | 68 ▲ 0.0% | 62 ▼ 9.2% | 62 ▲ 0.0% | 57 ▼ 8.5% | 57 ▲ 0.0% | 78 ▲ 36.5% | 78 ▲ 0.0% | 101 ▲ 30.7% | 101 ▲ 0.0% | |
| Net Profit Margin %Derived | 15.02% | 15.02% | 12.75% | 12.75% | 9.17% | 9.17% | 10.82% | 10.82% | 13.13% | 13.13% | |
| PAT Growth YoY %Derived | — | — | -9.18% | -9.18% | -8.49% | -8.49% | 36.54% | 36.54% | 30.70% | 30.70% | |
| Earnings Per Share (EPS ₹) | 21.78 | 21.78 ▲ 0.0% | 19.78 ▼ 9.2% | 19.78 ▲ 0.0% | 17.60 ▼ 11.0% | 17.60 ▲ 0.0% | 24.03 ▲ 36.5% | 24.03 ▲ 0.0% | 31.27 ▲ 30.1% | 31.27 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 2.8% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.0% | 3 ▲ 0.5% | 3 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | — | — | — | — | — | — | — | -0 | -0 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 0.0% | 0 ▲ 51.4% | 0 ▲ 0.0% | -0 ▼ 127.2% | -0 ▲ 0.0% | 0 ▲ 469.2% | 0 ▲ 0.0% | 0 ▼ 58.5% | 0 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 384 | 384 ▲ 0.0% | 426 ▲ 11.1% | 426 ▲ 0.0% | 566 ▲ 32.9% | 566 ▲ 0.0% | 640 ▲ 13.0% | 640 ▲ 0.0% | 686 ▲ 7.1% | 686 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 13.24% | 13.24% | 15.23% | 15.23% | 22.76% | 22.76% | 23.60% | 23.60% | 23.17% | 23.17% | |
| Employee Cost % of RevenueDerived | 12.02% | 12.02% | 15.31% | 15.31% | 17.99% | 17.99% | 19.07% | 19.07% | 18.18% | 18.18% | |
| Other Cost % of RevenueDerived | 45.87% | 45.87% | 44.36% | 44.36% | 35.97% | 35.97% | 30.82% | 30.82% | 31.23% | 31.23% | |
| Interest Coverage (x)Derived | 4.87x | 4.87x | 8.90x | 8.90x | 4.23x | 4.23x | 4.13x | 4.13x | 3.53x | 3.53x |
KRSNAA DIAGNOSTICS segment analysis : revenue and profit mix.
Disclosed business segments at KRSNAA DIAGNOSTICS with their share of revenue and profit, switchable between consolidated and standalone reporting.
KRSNAA DIAGNOSTICS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for KRSNAA DIAGNOSTICS.
Our AI distills the core fundamental drivers supporting KRSNAA DIAGNOSTICS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 23 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.05. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
KRSNAA DIAGNOSTICS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — KRSNAA DIAGNOSTICS is highlighted for quick read-across.
Quick Compare
KRSNAA DIAGNOSTICS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for KRSNAA DIAGNOSTICS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
KRSNAA DIAGNOSTICS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for KRSNAA DIAGNOSTICS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in KRSNAA DIAGNOSTICS stood at 63.2% of traded volume, against a 20-day average of 54.9%.
KRSNAA DIAGNOSTICS announcements: results, concalls, ratings, M&A.
Filings KRSNAA DIAGNOSTICS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
KRSNAA DIAGNOSTICS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 206 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Krsnaa Diagnostics Limited has informed the Exchange about Transcript
General Updates
Krsnaa Diagnostics Limited has informed the Exchange about the Shifting of Corporate Office of Registrar And Share Transfer Agent of The Company…
Analysts/Institutional Investor Meet/Con. Call Updates
Krsnaa Diagnostics Limited has informed the Exchange about Link of Recording
General Updates
Krsnaa Diagnostics Limited has informed the Exchange about General Updates
General Updates
Krsnaa Diagnostics Limited has informed the Exchange about General Updates
Investor decks & rating reports.
KRSNAA DIAGNOSTICS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue KRSNAA DIAGNOSTICS has declared, sequenced by announce and record date.
KRSNAA DIAGNOSTICS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
KRSNAA DIAGNOSTICS insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in KRSNAA DIAGNOSTICS as reported to SEBI — buying and selling signals from the people who know the business best.
KRSNAA DIAGNOSTICS insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Krsna Diagnostics (Mumbai) Private Limited | Insider | 27 Dec 2024 | buy | +22.9 K | ₹2 Cr. | ₹870.89 |
About KRSNAA DIAGNOSTICS: business, sector, key facts.
What KRSNAA DIAGNOSTICS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
KRSNAA DIAGNOSTICS operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: KRSNAA, BSE: 543328.

Krsnaa Diagnostics Limited is a prominent provider of diagnostic services across India, specializing in a comprehensive range of medical testing and imaging solutions. Their service portfolio encompasses a wide spectrum of diagnostic modalities, catering to the diverse needs of both individual patients and institutional clients. This diverse offering positions them as a significant player in the Indian healthcare landscape.
The company's core services fall under three major categories: radiology, pathology, and teleradiology. Radiology services likely encompass various imaging techniques such as X-rays, CT scans, MRIs, and ultrasound, providing detailed anatomical images for diagnosis. Pathology services involve the analysis of bodily fluids and tissues to detect diseases and abnormalities at a cellular level. Teleradiology, a crucial aspect of their offerings, allows for the remote interpretation of medical images, enabling the efficient dissemination of diagnostic expertise across geographically dispersed areas and improving access to specialist opinion.
Beyond individual tests, Krsnaa Diagnostics also offers a suite of pre-packaged health check-ups designed to assess specific health concerns or cater to particular demographics. These packages address common health issues, covering areas such as diabetes, heart health, liver function, kidney function, thyroid health, cancer risk assessment, and more. They also offer specialized packages targeting specific age groups, like senior citizen health checks, and address common conditions such as infections and fatigue. This targeted approach enhances accessibility and convenience for patients seeking preventative healthcare or focused diagnostic evaluations.
Krsnaa Diagnostics serves a broad client base, including public and private hospitals, medical colleges, and community health centers. This diverse clientele highlights their adaptability and significance within the healthcare ecosystem. Their reach across various healthcare sectors demonstrates their ability to meet the diagnostic needs of a wide range of patients and medical institutions. This widespread network positions them as a key contributor to the overall quality and accessibility of healthcare in India.
Established in 2010 and headquartered in Pune, India, Krsnaa Diagnostics has developed a strong presence within the country's diagnostic services sector. Their comprehensive service portfolio, coupled with their broad client base, positions them as a significant player in the Indian healthcare market, contributing to improved diagnostic capabilities and healthcare access across various segments of the population.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- HEALTH X PLATFORM (HEALTHX) Share PricePeer
- DR LAL PATH LABS (LALPATHLAB) Share PricePeer
- METROPOLIS HEALTHCARE (METROPOLIS) Share PricePeer
- SURAKSHA DIAGNOSTIC (SURAKSHA) Share PricePeer
- THYROCARE TECH (THYROCARE) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about KRSNAA DIAGNOSTICS (KRSNAA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of KRSNAA DIAGNOSTICS (KRSNAA)?
The current share price of KRSNAA DIAGNOSTICS (KRSNAA) is ₹528.75. Today, the stock has gained by ₹10.70 (2.07%), trading in a range of ₹509.55 to ₹540.50. The stock opened at ₹514.35 with a trading volume of 1,97,401 shares.
02Is KRSNAA DIAGNOSTICS stock a good investment for long-term?
KRSNAA DIAGNOSTICS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,720.22 Cr., P/E ratio of 17.54, ROE of 10.35%, and ROCE of 8.96%. The dividend yield stands at 0.38%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of KRSNAA DIAGNOSTICS stock?
The 52-week high price of KRSNAA DIAGNOSTICS (KRSNAA) is ₹838.00, while the 52-week low is ₹463.10. Currently trading at ₹528.75, the stock is 14.18% above its 52-week low and 36.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy KRSNAA DIAGNOSTICS stock at the current price?
Whether to buy KRSNAA DIAGNOSTICS stock at ₹528.75 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.54 and P/B ratio of 1.66. Today's performance shows a gain of 2.07%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of KRSNAA DIAGNOSTICS and when is the next dividend?
KRSNAA DIAGNOSTICS offers a dividend yield of 0.38%, which means for every ₹100 invested at the current price of ₹528.75, you can expect to receive approximately ₹0.38 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of KRSNAA DIAGNOSTICS?
KRSNAA DIAGNOSTICS's key financial metrics include: P/E Ratio: 17.54, P/B Ratio: 1.66, ROE: 10.35%, ROCE: 8.96%, Dividend Yield: 0.38%, EPS: ₹7.58, Book Value: ₹302.23, and Debt-to-Equity: 0.55. The company's market cap stands at ₹1,720.22 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is KRSNAA DIAGNOSTICS stock performing today in the market?
KRSNAA DIAGNOSTICS stock opened at ₹514.35 and is currently trading at ₹528.75, showing a gain of ₹10.70 (2.07%). The intraday high is ₹540.50 and low is ₹509.55. The trading volume stands at 1,97,401 shares, indicating moderate market participation today.
08What is the P/E ratio of KRSNAA DIAGNOSTICS and what does it indicate?
KRSNAA DIAGNOSTICS has a Price-to-Earnings (P/E) ratio of 17.54, which means investors are willing to pay 17.54 for every ₹1 of earnings. With an EPS of ₹7.58, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about KRSNAA DIAGNOSTICS (KRSNAA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.